In 'Episode 1' of the series on "Exploring urology: A roadmap for medical students", Prof. Henk Van der Poel (NL) and Dr. Alexander Ng (GB) introduce the field of urology, offering insights into its broad scope and unique appeal.

In "Introduction to urology" Prof. Van der Poel and Dr. Ng discuss how urology combines surgical precision with medical innovation, covering everything from common treatments to advanced technologies that improve patient care. Highlighting urology’s pivotal role in healthcare, they emphasise the opportunities for specialisation and close collaborations with other disciplines.

Join us as we uncover why urology is not only an essential part of modern healthcare but also a dynamic and rewarding career choice. 

At ICS24 (International Continence Society Annual Meeting), Dr. José Batista (ES) presented his abstract, “Artificial intelligence to read urodynamic tracings: Could we skip a human reading?”.  In this episode of EAU Podcasts, Dr. Batista discusses the rationale and key findings of his study, exploring whether AI can interpret CMG traces reliably enough to be integrated into daily clinical practice.

To learn more on this study, read the abstract here.

For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In this interview from UROonco24, Dr. Juan Gómez Rivas (ES) and Dr. Ursula Vogl (CH) discuss advancements in genomic profiling and the use of PARP inhibitors in treating metastatic prostate cancer, with a focus on genomic profiling, patient selection and toxicity management.

This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.

For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In this episode, Dr. Martin Stentebjerg Skøtt (DK) presents findings from a recently published systematic review on the topic of "Endoscopic balloon dilatation and incision for treating primary obstructive megaureter in children".

Historically, ureteral re-implantation has been the gold standard for addressing primary obstructive megaureter (POM) in children, but its challenges, particularly in infants, have spurred interest in less invasive methods. Dr. Skott discusses the effectiveness, safety, and benefits of endoscopic management as an alternative to the traditional surgical approach.

Dr. Skøtt also discussses potential complications, the need for long-term follow-up, and the importance of future research to refine treatment protocols for better patient outcomes.

Join us for this insightful conversation as Dr. Martin Skott sheds light on cutting-edge approaches to managing primary obstructive megaureter in children.  Tune in and stay informed!

In this interview, medical oncologist Dr. Elena Castro (ES) and Dr. Gianluca Giannarini (IT) discuss the challenges of managing treatment-related toxicity and quality of life for PCa patients, particularly hormone-sensitive patients.

This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.

For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In this interview recorded at UROonco24 in Budapest earlier in the year, Dr. Gianluca Giannarini (IT) talks with Prof. Geert De Meerleer (BE) about the quality of life for patients with metastatic prostate cancer (mPCa) that are undergoing treatment. Their conversation features the role and safety of radiation therapy in patients with de novo metastatic hormone sensitive prostate cancer.

This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.

In 'Episode 3' of the series "Voices of tomorrow's urologists (ESRU): Journeying through Europe's resident perspectives", Dr. Enrico Checcucci (IT) and Assoc. Prof. Stefano Puliatti (IT) discuss "Surgical training unveiled: Exploring new tech and standardisation trends".

This insightful talk highlights the evolving landscape of urological surgical training, addressing the integration of new technologies such as 3D printing and virtual simulators. The conversation also underscores the need for standardised training pathways and explores the challenges posed by the heavy reliance on patient-based training in the early stages of the learning curve.

Dr. Checcucci shares key findings from a Europe-wide survey on surgical training, shedding light on the current gaps and future directions. The episode offers valuable perspectives on how young urologists can benefit from a more structured and technologically enhanced training environment to ensure better surgical outcomes.

This EAU podcast has been developed with financial support from Pfizer Inc for healthcare professionals based in the EU and UK. The content discussed here was up to date at the time of recording in June 2024 and may not be suitable in your local market. The EAU has retained full editorial control.

In this episode, the panel chair of the EAU guidelines on prostate cancer, Prof. Philip Cornford (GB) is at UROonco24 in Budapest, and talks to medical oncologist Dr. Ursula Vogl (CH) on the role of genetic testing for prostate cancer.

Dr. Vogl discusses why genetic testing is important, and defines both somatic (tissue) testing, and germline testing. She shares her opinion on why ideally both should be done, and when, as well as an explanation of the guidelines.

To keep updated on prostate cancer developments, go to the UROONCO Prostate Cancer Educational Platform.

For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

PP-UNP-GBR-10244.  September 2024 

In this podcast recorded live at ESMO 2024 in Barcelona, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talked to Prof. Hiroshi Kitamura (JP) about his presentation on the JCOG1019 study results: An open-label, non-inferiority, randomised phase III study comparing the effectiveness of watchful waiting (WW) and intravesical Bacillus Calmette-Guérin (BCG) in patients with high-grade pT1 (HGT1) bladder cancer with pT0 on the second transurethral resection (TUR) specimen.

Prof. Kitamura shares details of the study rationale, summarises the results, and discusses how these results could be implemented into clinical practice.

UROONCO BCa chief editor Dr. Benjamin Pradere talks to Assoc. Prof. Andrea Necchi (IT) at EMSO 2024 on the results of the interim analysis of SunRISe-4 study: TAR-200 plus cetrelimab or CET alone as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or refuse neoadjuvant cisplatin-based chemotherapy. 

Assoc. Prof. Necchi shares details of the study rationale and design, followed by an analysis of the results, and how these data could positively impact the future of treatment options for patients. 

According to Assoc. Prof. Necchi, the SunRISe-4 study results show for the first time that an intravesical treatment with TAR-200, combined with a systemic PD-1 inhibitor, could potentially result in a complete pathological response in a high proportion of patients.